39070196|t|The Antinociceptive Effects of Combined Treatment With Atorvastatin and Vitamin C in the Chronic Constriction Injury Model of Rats.
39070196|a|Introduction: Neuropathic pain (NP) is caused by damage to the somatosensory system. Nerve damage often results in chronic pain states, including hyperalgesia and allodynia. This study aims to evaluate the anti-nociceptive effects of atorvastatin, vitamin C, and their combination on various laboratory tests in an experimental model NP in rats. Methods: To assess the analgesic effects of atorvastatin (5 and 10 mg/kg), vitamin C (500 mg/kg), and their co-administration on chronic constriction injury (CCI) was induced in rats. Behavioral tests, motor nerve conduction velocity (MNCV), pro-inflammatory cytokines, and oxidative markers were measured. Furthermore, histopathological examination was performed. Results: In the present study, it was found that the CCI model can significantly cause hyperalgesia and allodynia on the 21st postoperative day. It was found that the co-administration of vitamin C and atorvastatin has attenuating effects on allodynia and hyperalgesia. Co-administration of vitamin C and atorvastatin also improved MNCV. In the treatment groups, the inflammatory reactions and oxidative markers decreased. Moreover, the co-administration of atorvastatin and vitamin C decreased the perineural inflammation around the sciatic nerve. Conclusion: The results of this study showed that vitamin C potentiates the analgesic effects of atorvastatin in this model of experimental pain, and simultaneous consumption of these medications may be considered as effective therapeutics for NP. The protective properties of atorvastatin, and vitamin C, and their combination on the NP that were assessed can be regarded as a novelty for this study. Highlights: The co-administration of atorvastatin and vitamin C significantly decreases inflammatory cytokines.The co-administration of atorvastatin and vitamin C significantly decreases stress oxidant markers.The co-administration of atorvastatin and vitamin C significantly attenuated nociceptive effects. Plain Language Summary: Nerve damage causes the deposition of inflammatory factors and or oxidative stress at the site of injury, which in turn activates glial cells that are involved in increasing the inflammatory process by producing and releasing pro-inflammatory agents and oxidative stress. Among statins, atorvastatin is a drug to reduce inflammation, and its effectiveness has been recorded as an antioxidant effect. Vitamin C is known as a neuroprotective agent. Ascorbate inhibits the production of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in monocytes in high doses (20 mM) by inhibiting them. The rats were randomly divided into 7 groups of 10 animals as follows: 1: Sham-operated, 2: Chronic constriction injury (CCI), 3: CCI+vitamin C (500 mg/kg), 4: CCI+atorvastatin (5 mg/kg), 5: CCI+atorvastatin (10 mg/kg), 6: CCI+vitamin C (500 mg/kg)+atorvastatin (5 mg/kg), and 7: CCI+vitamin C (500 mg/kg)+atorvastatin (10 mg/kg). The results of the present study indicated that the anti-inflammatory, antioxidant, and neuroprotective properties of vitamin C and atorvastatin improved the effects of CCI in an empirical neuropathic in rats. Moreover, it was shown that the associated treatment with vitamin C and atorvastatin can reduce inflammatory factors, such as TNF-alpha and IL-6, and oxidative markers, such as glutathione peroxidase (GPx), superoxide dismutase (SOD), and malonaldehyde (MDA), while the nerve conduction velocity enhanced and inflammation decreased in histology studies in CCI rats.
39070196	55	67	Atorvastatin	Chemical	MESH:D000069059
39070196	72	81	Vitamin C	Chemical	MESH:D001205
39070196	89	116	Chronic Constriction Injury	Disease	MESH:D020208
39070196	126	130	Rats	Species	10116
39070196	146	162	Neuropathic pain	Disease	MESH:D009437
39070196	164	166	NP	Disease	MESH:D009437
39070196	217	229	Nerve damage	Disease	MESH:D000080902
39070196	247	259	chronic pain	Disease	MESH:D059350
39070196	278	290	hyperalgesia	Disease	MESH:D006930
39070196	295	304	allodynia	Disease	MESH:D006930
39070196	343	354	nociceptive	Disease	MESH:D059226
39070196	366	378	atorvastatin	Chemical	MESH:D000069059
39070196	380	389	vitamin C	Chemical	MESH:D001205
39070196	466	468	NP	Disease	MESH:D009437
39070196	472	476	rats	Species	10116
39070196	522	534	atorvastatin	Chemical	MESH:D000069059
39070196	553	562	vitamin C	Chemical	MESH:D001205
39070196	607	634	chronic constriction injury	Disease	MESH:D020208
39070196	636	639	CCI	Disease	MESH:D020208
39070196	656	660	rats	Species	10116
39070196	724	746	inflammatory cytokines	Disease	MESH:D000080424
39070196	896	899	CCI	Disease	MESH:D020208
39070196	930	942	hyperalgesia	Disease	MESH:D006930
39070196	947	956	allodynia	Disease	MESH:D006930
39070196	1031	1040	vitamin C	Chemical	MESH:D001205
39070196	1045	1057	atorvastatin	Chemical	MESH:D000069059
39070196	1085	1094	allodynia	Disease	MESH:D006930
39070196	1099	1111	hyperalgesia	Disease	MESH:D006930
39070196	1134	1143	vitamin C	Chemical	MESH:D001205
39070196	1148	1160	atorvastatin	Chemical	MESH:D000069059
39070196	1210	1222	inflammatory	Disease	MESH:D007249
39070196	1301	1313	atorvastatin	Chemical	MESH:D000069059
39070196	1318	1327	vitamin C	Chemical	MESH:D001205
39070196	1353	1365	inflammation	Disease	MESH:D007249
39070196	1442	1451	vitamin C	Chemical	MESH:D001205
39070196	1489	1501	atorvastatin	Chemical	MESH:D000069059
39070196	1532	1536	pain	Disease	MESH:D010146
39070196	1636	1638	NP	Disease	MESH:D009437
39070196	1669	1681	atorvastatin	Chemical	MESH:D000069059
39070196	1687	1696	vitamin C	Chemical	MESH:D001205
39070196	1727	1729	NP	Disease	MESH:D009437
39070196	1831	1843	atorvastatin	Chemical	MESH:D000069059
39070196	1848	1857	vitamin C	Chemical	MESH:D001205
39070196	1882	1904	inflammatory cytokines	Disease	MESH:D000080424
39070196	1930	1942	atorvastatin	Chemical	MESH:D000069059
39070196	1947	1956	vitamin C	Chemical	MESH:D001205
39070196	2029	2041	atorvastatin	Chemical	MESH:D000069059
39070196	2046	2055	vitamin C	Chemical	MESH:D001205
39070196	2081	2092	nociceptive	Disease	MESH:D059226
39070196	2126	2138	Nerve damage	Disease	MESH:D000080902
39070196	2164	2176	inflammatory	Disease	MESH:D007249
39070196	2304	2316	inflammatory	Disease	MESH:D007249
39070196	2356	2368	inflammatory	Disease	MESH:D007249
39070196	2413	2425	atorvastatin	Chemical	MESH:D000069059
39070196	2446	2458	inflammation	Disease	MESH:D007249
39070196	2526	2535	Vitamin C	Chemical	MESH:D001205
39070196	2573	2582	Ascorbate	Chemical	MESH:D001205
39070196	2610	2623	interleukin-6	Gene	3569
39070196	2625	2629	IL-6	Gene	3569
39070196	2635	2662	tumor necrosis factor-alpha	Gene	7124
39070196	2664	2673	TNF-alpha	Gene	7124
39070196	2734	2738	rats	Species	10116
39070196	2822	2849	Chronic constriction injury	Disease	MESH:D020208
39070196	2851	2854	CCI	Disease	MESH:D020208
39070196	2860	2863	CCI	Disease	MESH:D020208
39070196	2864	2873	vitamin C	Chemical	MESH:D001205
39070196	2890	2893	CCI	Disease	MESH:D020208
39070196	2894	2906	atorvastatin	Chemical	MESH:D000069059
39070196	2921	2924	CCI	Disease	MESH:D020208
39070196	2925	2937	atorvastatin	Chemical	MESH:D000069059
39070196	2953	2956	CCI	Disease	MESH:D020208
39070196	2957	2966	vitamin C	Chemical	MESH:D001205
39070196	2979	2991	atorvastatin	Chemical	MESH:D000069059
39070196	3010	3013	CCI	Disease	MESH:D020208
39070196	3014	3023	vitamin C	Chemical	MESH:D001205
39070196	3036	3048	atorvastatin	Chemical	MESH:D000069059
39070196	3118	3130	inflammatory	Disease	MESH:D007249
39070196	3179	3188	vitamin C	Chemical	MESH:D001205
39070196	3193	3205	atorvastatin	Chemical	MESH:D000069059
39070196	3230	3233	CCI	Disease	MESH:D020208
39070196	3250	3261	neuropathic	Disease	MESH:D009437
39070196	3265	3269	rats	Species	10116
39070196	3329	3338	vitamin C	Chemical	MESH:D001205
39070196	3343	3355	atorvastatin	Chemical	MESH:D000069059
39070196	3367	3379	inflammatory	Disease	MESH:D007249
39070196	3397	3406	TNF-alpha	Gene	7124
39070196	3411	3415	IL-6	Gene	3569
39070196	3478	3498	superoxide dismutase	Gene	6647
39070196	3500	3503	SOD	Gene	6647
39070196	3510	3523	malonaldehyde	Chemical	MESH:D008315
39070196	3525	3528	MDA	Chemical	MESH:D015104
39070196	3580	3592	inflammation	Disease	MESH:D007249
39070196	3627	3630	CCI	Disease	MESH:D020208
39070196	3631	3635	rats	Species	10116
39070196	Cotreatment	MESH:D000069059	MESH:D001205
39070196	Association	MESH:D008315	6647
39070196	Negative_Correlation	MESH:D000069059	MESH:D059226
39070196	Negative_Correlation	MESH:D001205	MESH:D020208
39070196	Negative_Correlation	MESH:D000069059	MESH:D010146
39070196	Negative_Correlation	MESH:D001205	MESH:D006930
39070196	Negative_Correlation	MESH:D001205	MESH:D059226
39070196	Negative_Correlation	MESH:D000069059	MESH:D000080424
39070196	Negative_Correlation	MESH:D001205	MESH:D010146
39070196	Negative_Correlation	MESH:D001205	MESH:D009437
39070196	Negative_Correlation	MESH:D000069059	MESH:D020208
39070196	Association	MESH:D008315	MESH:D015104
39070196	Negative_Correlation	MESH:D000069059	MESH:D007249
39070196	Negative_Correlation	MESH:D001205	MESH:D007249
39070196	Negative_Correlation	MESH:D001205	MESH:D000080424
39070196	Association	MESH:D015104	6647
39070196	Negative_Correlation	MESH:D000069059	MESH:D006930
39070196	Association	MESH:D000069059	3569
39070196	Negative_Correlation	MESH:D000069059	MESH:D009437

